will hims stop selling semaglutide stock plunges as Lilly's Zepbound weight-loss drug shortage ends Novo Nordisk and Eli Lilly

GLP-1 Antagonists Explained A GLP-1 antagonist does the opposite job

The safety profile of dual agonists is similar to pure GLP-1 agonists, with the main difference being slightly higher rates of GI side effects

Alternative Formulations if Injections Feel Risky If you prefer to avoid injections or worry that medication timing interacts with your post-cholecystectomy bile flow, oral semaglutide is available through PlexusDx starting at $249/month

In SURMOUNT-5 (NEJM 2025), tirzepatide produced 20.2% average weight loss vs

GLP-1 therapies, which effectively regulate blood glucose levels and support weight loss, have gained widespread acceptance among healthcare providers (HCPs) and patients